Telehealth access to abortion and miscarriage management medication mifepristone is on the chopping block after a federal appeals court sought to roll back nationwide access to the drug on May 1. After pharmaceutical companies appealed the decision to the U.S. Supreme Court, the high court placed the ruling on hold until May 11. In Montana, a sizeable state with few abortion care providers, telehealth access to mifepristone is critical, Helen We…